CINELLU, Maria Agostina
 Distribuzione geografica
Continente #
NA - Nord America 18.643
AS - Asia 5.251
EU - Europa 3.264
SA - Sud America 3.156
AF - Africa 222
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 13
AN - Antartide 1
Totale 30.563
Nazione #
US - Stati Uniti d'America 18.447
BR - Brasile 2.825
SG - Singapore 2.076
CN - Cina 1.731
UA - Ucraina 1.229
DE - Germania 453
SE - Svezia 453
VN - Vietnam 386
HK - Hong Kong 357
IT - Italia 272
FI - Finlandia 200
FR - Francia 197
GB - Regno Unito 192
AR - Argentina 129
IN - India 84
RU - Federazione Russa 81
TR - Turchia 80
MX - Messico 76
BD - Bangladesh 71
CA - Canada 70
IQ - Iraq 66
ZA - Sudafrica 65
JP - Giappone 50
UZ - Uzbekistan 50
EC - Ecuador 47
ID - Indonesia 47
CO - Colombia 43
MA - Marocco 43
PK - Pakistan 38
VE - Venezuela 36
BE - Belgio 31
JO - Giordania 27
KE - Kenya 25
TN - Tunisia 25
PY - Paraguay 24
KR - Corea 22
PL - Polonia 21
KZ - Kazakistan 19
ES - Italia 18
NL - Olanda 18
DZ - Algeria 17
AZ - Azerbaigian 16
NP - Nepal 16
UY - Uruguay 16
CL - Cile 15
LB - Libano 14
AE - Emirati Arabi Uniti 13
EG - Egitto 13
IE - Irlanda 13
IR - Iran 13
AU - Australia 12
SA - Arabia Saudita 12
CZ - Repubblica Ceca 10
PE - Perù 10
PA - Panama 9
BY - Bielorussia 8
LT - Lituania 8
OM - Oman 8
BO - Bolivia 7
CI - Costa d'Avorio 7
DO - Repubblica Dominicana 7
HN - Honduras 7
JM - Giamaica 7
RO - Romania 7
SN - Senegal 7
AT - Austria 6
BA - Bosnia-Erzegovina 6
CR - Costa Rica 6
ET - Etiopia 6
EU - Europa 6
GR - Grecia 6
GT - Guatemala 6
IL - Israele 6
KG - Kirghizistan 6
PH - Filippine 6
AL - Albania 5
BG - Bulgaria 5
GE - Georgia 5
NI - Nicaragua 5
PT - Portogallo 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AO - Angola 4
HU - Ungheria 4
MY - Malesia 4
PS - Palestinian Territory 4
BH - Bahrain 3
CH - Svizzera 3
ML - Mali 3
MN - Mongolia 3
NG - Nigeria 3
QA - Qatar 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BN - Brunei Darussalam 2
GY - Guiana 2
LV - Lettonia 2
MD - Moldavia 2
RS - Serbia 2
Totale 30.540
Città #
Dallas 12.310
Chandler 1.123
Singapore 1.122
Jacksonville 727
San Jose 661
Ashburn 390
Princeton 369
Hong Kong 341
Beijing 340
Nanjing 272
Dearborn 227
São Paulo 178
Wilmington 174
Lauterbourg 157
Ann Arbor 139
Ho Chi Minh City 134
Boardman 108
Shanghai 107
Los Angeles 105
Nanchang 102
Sassari 96
Santa Clara 92
Woodbridge 91
Belo Horizonte 79
Hanoi 79
Rio de Janeiro 77
Washington 73
Shenyang 67
Tianjin 67
Hebei 64
Brasília 55
Changsha 52
Columbus 50
The Dalles 49
Mountain View 48
Kunming 46
Jiaxing 45
Tokyo 44
New York 43
Tashkent 43
Andover 41
Curitiba 40
San Francisco 40
Houston 39
Hangzhou 38
Porto Alegre 37
Johannesburg 33
Jinan 32
Toronto 32
Brussels 31
Buffalo 31
Baghdad 29
Council Bluffs 29
Zhengzhou 28
Ningbo 26
Salvador 26
San Mateo 26
Amman 25
Guarulhos 25
Campinas 24
Goiânia 24
Orem 24
Da Nang 23
Ribeirão Preto 23
Florence 22
Buenos Aires 21
Leawood 21
Nairobi 20
Seoul 20
Ankara 19
Dhaka 19
Frankfurt am Main 19
Guangzhou 19
Jakarta 19
Munich 19
Warsaw 19
Augusta 18
Denver 18
London 18
Norwalk 18
Santo André 18
Brooklyn 17
Contagem 17
Maceió 17
Manchester 17
Osasco 17
Chicago 16
Haiphong 16
Izmir 16
Montreal 16
Phoenix 16
São Bernardo do Campo 16
Atlanta 15
Baku 15
Caxias do Sul 15
Mexico City 15
Monmouth Junction 15
Piracicaba 15
Stockholm 15
Viamão 15
Totale 21.700
Nome #
1,1' BIS(DIPHENYLPHOSPHINO)FERROCENE COMPLEXES OF PLATINUM(II) AND PLATINUM(I) - CRYSTAL AND MOLECULAR-STRUCTURE OF [(FE(ETA-5-C5H4PPH2)PT(MU-H)(MU-CO)PT(FE(ETA-5-C5H4PPH2)2)][BF4]-0.5H2O 10.307
[Au2(phen2Me)2(?-O)2](PF6)2, a novel dinuclear gold(III) complex showing excellent antiproliferative properties 187
ADDUCTS AND CYCLOMETALLATED DERIVATIVES OF PALLADIUM(II) WITH SOME 1,4-BENZODIAZEPIN-2-ONES - CRYSTAL AND MOLECULAR-STRUCTURE OF TRANS-DICHLOROBIS[7-CHLORO-1-(CYCLOPROPYLMETHYL)-1,3-DIHYDRO-5-PHENYL-2H-1,4-BENZODIAZEPIN-2-ONE]PALLADIUM(II) 177
Assembly of symmetrical and unsymmetrical platinum(II) rollover complexes with bidentate phosphine ligands 175
Chemistry, antiproliferative properties, tumor selectivity and molecular mechanisms of novel gold(III) compounds for cancer treatment: a systematic study 175
Auraoxetanes as Plausible Intermediates in the Oxidation of Alkenes by Oxygen- Transfer Reaction from Gold(III) Oxo Complexes. 173
Chiral cyclometalation of 6-(1-phenylbenzyl)-2,2’-bipyridine. 170
Gold(III) Adducts with Chiral Pyridinyl-Oxazolines. Synthesis, Reactivity of the Coordinated Ligands and Structural Characterizations 166
Catalytic and Biological studies of Au(III) complexes with pyridinyl-oxazoline ligands 166
2D-DIGE analysis of ovarian cancer cell responses to cytotoxic gold compounds. 163
Activation of a C-H bond in a pyridine ring. Reaction of 6-substituted 2,2 '-bipyridines with methyl and phenyl platinum(II) derivatives: N ',C(3)-"rollover" cyclometalation 162
[Au(pyb-H)(mnt)]: A novel gold(III) 1,2-dithiolene cyclometalated complex with antimicrobial activity (pyb-H = C-deprotonated 2-benzylpyridine; mnt = 1,2-dicyanoethene-1,2-dithiolate) 160
ADDUCTS AND CYCLOMETALATED DERIVATIVES OF PALLADIUM(II) WITH 2-(1-METHYLBENZYL)PYRIDINE RID D-3096-2011 159
New complexes of palladium(II) with chelating heterocyclic nitrogen ligands. Characterization and catalytic activity in CO-styrene copolimerization. Crystal structure of [Pd(bipy)2][BAr’4]2, Ar’ = [3,5-(CF3)2C6H3] 158
Chiral methyl derivatives of platinum(II) with 2-substituted pyridines 158
Complessi mono e dinucleari di oro (i) e oro (iii): applicazioni in campo farmacologico e catalitico 157
Complessi di Oro(III) con leganti pincer NCN piridinici 155
C(3) aurated 1,4-benzodiazepin-2-ones. Synthesis and characterization. Crystal structure of (L)Au[P(C6H4CH3-4)(3)] (HL = 7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one, DIAZEPAM) 155
Caged noble metals: Encapsulation of a cytotoxic platinum(II)-gold(I) compound within the ferritin nanocage 155
Chemistry of Gold(III) Complexes with Nitrogen and Oxygen Ligands 154
Gold(III) Complexes with 2-Substituted Pyridines as Experimental Anticancer Agents: Solution Behaviour, Reaction with Model Proteins, Antiproliferative Properties. 153
Cytotoxic Properties of a New Organometallic Platinum(II) Complex and its Gold(I) Heterobimetallic Derivatives 151
Reactivity of Ph2P(O)py-2 with platinum(II) alkyl derivatives - Building-up of a chiral phosphorus atom through C,N-cyclometallation RID D-3096-2011 148
Rollover-assisted C(sp2)-C(sp3) bond formation 146
Synthesis, Solution Behavior, Molecular and Supramolecular Structures of the Water- soluble Gold(I) Saccharinate Complexes M[Au(Sac)2] (M = Na, K, NH4) 146
Gold(III) adducts of 2-vinyl- and 2-ethylpyridine and cyclometallated derivatives of 2-vinylpyridine: Crystal structure of the cyclometallated derivative [Au(k(2)-C,N-CH(2)CH(Cl)-C(5)H(4)N)(PPh(3))Cl][PF(6)] RID D-3096-2011 145
Chemistry and biology of three representative gold(III) compounds as prospective anticancer agents 143
Dinuclear platinum(II) complexes with bridging twofold deprotonated 2,2 ': 6 ',2 ''-terpyridine. New molecules with a 3,5-diplatinated-pyridyl inner core: [Pt-2(terpy-2H)(Me)(2)(L)(2)], [Pt-2(terpy-2H)(X)(2)(L)(2)] and [Pt-2(terpy-2H)(H)(2)(L)(2)] (L = neutral ligand; X = halide) - Crystal and molecular structure of [Pt-2(terpy-2H)(Cl)(2)(PPh3)(2)] RID D-3096-2011 143
New Variations on the Theme of Gold(III) C ∧ N ∧ N Cyclometalated Complexes as Anticancer Agents: Synthesis and Biological Characterization 142
Synthesis and properties of gold alkene complexes. Crystal structure of [Au(bipyoXyl)(g2-CH2=CHPh)](PF6) and DFT calculations on the model cation [Au(bipy)(g2-CH2=CH2)]+ 142
Complessi mono- ed eterodinucleari di oro, platino e palladio: sintesi e caratterizzazione 141
Gold(III) derivatives with a-diimines as potential antitumor agents: synthesis and characterization 140
A Gold(III) Push-Pull Mixed-Ligand Complex for ICT Applications: Synthesis, Characterization, and DFT Investigation 140
Biological studies on a new class of gold complexes with pyridinyl-benzoimidazole 139
Cyclopalladation of 6-substituted-2,2’-bipyridines. Metallation of unactivated methyl groups vs. aromatic C-H activation 138
N^N^C Platinum(II) and Palladium(II) cyclometallates of 6,6’-diphenyl-2,2’-bipyridine, L. Crystal and molecular structure of [Pd(L-H)Cl] 136
m-Oxo and alkoxo complexes of gold(III) with 6-alkyl-2,2’-bipiridines. Synthesis, characterization and X-ray structures 136
Dinuclear Gold(III) Complexes as Potential Anticancer Agents. Structure, Reactivity and Biological Profile of a Series of Gold(III) Oxo-Bridged Derivatives 135
Large Effect of a Small Substitution: Competition of Dehydration with Charge Retention and Coulomb Explosion in Gaseous [(bipyR)Au(μ-O)2Au(bipyR)]2+ Dications 135
N,C "Rollover" cyclometalated platinum(II) hydrides: Mono- and polynuclear derivatives 133
Complessi pincer NCN di Au(III) quali possibili agenti antitumorali 132
Synthesis, structural characterization and in vitro cytotoxicity of gold complexes with 2-(2-pyridyl)benzimidazole. Gold)III) vs. cold(I), mono- vs. binuclear derivatives 132
Cyclometalated Platinum(II) hydrides with nitrogen ligands 131
FAB Mass Spectrometry of Palladium(II) Derivatives with 1,4-Benzodiazepin-2-ones: Evidence of the Stability of Cyclometallated Species 131
Biological studies on a new class of gold complexes with pyridinyl-benzoimidazole 130
Gold-Alkyne Complexes 128
Cyclometalation of 2,2'-Bipyridine, Mono- and Dinuclear C,N Platinum(II) Derivatives 127
Electronic and steric effects in rollover C-H bond activation 125
Complessi NCN di Oro(III) con leganti pincer aromatici con gruppi piridilici 125
Electrochemical behaviour of cyclometallated gold(III) complexes. Evidence of transcyclometallation in the fate of electroreduced species 125
Metallation of unactivated methyl groups. Platinum(II) derivatives with 6-alkyl-2,2’-bipyridines 124
Platinum(II), palladium(II) and gold(III) adducts and cyclometalated derivatives of 6-methoxy-2,2’-bipyridine: A comparative study 123
Synthesis and Characterization of Square-planar Palladium(II), Platinum(II) and Rhodium(I) Complexes with a Chiral Pyridylphosphine Hybrid Ligand 123
Electrochemical properties of gold(III) complexes with 2,2 '-bipyridine and oxygen ligands 122
Unusual Platinum Hydrides With Nitrogen Ligands 121
Platinum(II)-Cyclometalated “Roll-over” Complexes with a Chiral Pinene-Derived 2,2'-Bipyridine 121
Exploring the biochemical mechanisms of cytotoxic gold compounds: a proteomic study 121
Rollover cyclometalation with 2-(2’-Pyridyl)quinoline 120
Heterobimetallic rollover derivatives 120
Gold(III) Complexes with 2-Substituted Pyridines as Experimental Anticancer Agents: Solution Behaviour, Reactions with Model Proteins, Antiproliferative Properties 120
Exploring the potential of gold(III) cyclometallated compounds as cytotoxic agents: variations on the C^N theme 119
mu-Oxo and alkoxo complexes of gold(III) with 6-alkyl-2,2 '-bipyridines. Synthesis, characterization and X-ray structures 119
Palladium(II) and platinum(II)-C-(3)-substituted 2,2 '-bipyridines RID D-3096-2011 118
Synthesis, characterization and evaluation of gold complexes as anti microbial compounds 118
Cytotoxic gold compounds showing selectivity between cancerous and normal cells: synthesis and biological characterization. 117
Reactivity of 1,3-bis(2-pyridyl)benzene, N boolean AND CH boolean AND N, with gold(III) chlorides: salts, adducts and cyclometalated pincer derivatives. Crystal and molecular structures of [HN boolean AND CH boolean AND N][AuCl4], [Au(N boolean AND C boolean AND N)Cl][PF6] and [Au(N boolean AND C boolean AND N)Cl(PPh3)(2)][PF6] 117
Complessi di oro con leganti imidazolici di interesse farmacologico 116
Synthesis and Characterization of Gold(III) Adducts and Cyclometallated Derivatives with 6-Benzyl- and 6-Alkyl-2,2’-bipyridines 115
Cyclometallated Derivatives of Platinum(II) derived from 6-(tert-Butyl)-2,2’-bipyridine (HL). Crystal and Molecular Structure of [Pt(L)Cl] 115
Protein Recognition of Gold-Based Drugs: 3D Structure of the Complex Formed When Lysozyme Reacts with Aubipyc 114
The first gold(III) dinuclear cyclometallated derivatives with a single oxo bridge 113
CYCLOMETALATED DERIVATIVES OF PLATINUM(II) DERIVED FROM 1,4-BENZODIAZEPIN-2-ONES - CRYSTAL AND MOLECULAR-STRUCTURE OF PT(L)(HL)CL (HL=7-CHLORO-1,3-DIHYDRO-1-METHYL-5-PHENYL-2H-1,4-BENZODIAZEPIN-2-ONE, DIAZEPAM), A MOLECULE CONTAINING A NEUTRAL AND A DEPROTONATED 1,4-BENZODIAZEPIN-2-ONE 112
Reaction of gold(III) oxo complexes with alkenes. Synthesis of unprecedented gold alkene complexes, [Au(N,N)(alkene)][PF6]. Crystal structure of [Au(bipy(ip))(eta(2)-CH2=CHPh)][PF6] (bipy(ip)=6-isopropyl-2,2 '-bipyridine) 112
Synthesis and molecular structure of [Pd{CH2CH2C(O)Me}(HL)][BAr '(4)] (HL=6-Me-2,2 '-bipyridine, Ar '=3,5-(CF3)(2)C6H3), an intermediate relevant to ethene/CO copolymerization 112
Fast-atom Bombardment Mass Spectrometry and Collisional Spectroscopy in the Structural Characterization of Underivatized 1,4-Benzodiazepines 112
Gold(III) derivatives with α-diimines as potential antitumor agents: synthesis and characterisation 111
Palladium(II) and platinum(II) derivatives with N,O ligands 110
SYNTHESIS AND CHARACTERIZATION OF GOLD(III) ADDUCTS AND CYCLOMETALATED DERIVATIVES WITH 2-SUBSTITUTED PYRIDINES - CRYSTAL-STRUCTURE OF [AU(NC5H4(CME(2)C(6)H(4))-2)CL-2] 110
Comportamento catodico di addotti di Au(III) con 2,2’-bipiridine 110
Complessi di Pt(II) con 1,2-bis(2-piridil)benzene 110
Organogold(III) compounds as experimental anticancer agents: chemical and biological profiles. 110
FAB Mass Spectrometry of Au(I) Complexes with 1,4-Benzodiazepin-2-ones 109
Gold saccharinato derivatives as potential antimalarial agents 109
Synthesis and characterization of mononuclear amidogold(III) complexes - Crystal structure of [Au(N2C10H7(CMe2C6H4)-6](NHC6H3Me2-2,6)][PF6] - Oxidation of 4-methylaniline to azotoluene RID D-3096-2011 109
Gold(III) derivatives with anionic oxygen ligands: mononuclear hydroxo, alkoxo and acetato complexes. Crystal structure of [Au(bpy)(OMe)(2)][PF6] 108
Ferritin nanocages loaded with gold ions induce oxidative stress and apoptosis in MCF-7 human breast cancer cells 108
Solution chemistry and cytotoxic properties of novel organogold(III) compounds 107
Synthesis, structural characterization and in vitro cytotoxicity of gold complexes with 2-(2-pyridyl)benzimidazole. Gold(III) vs. Gold(I), mononuclear vs. binuclear derivatives 107
Modification of HIV-1 reverse transcriptase and integrase activity by gold(III) complexes in direct biochemical assays. 107
Mono and Dinuclear Gold(I) Complexes with Neutral and Deprotonated 1,4-Benzodiazepin-2-ones. Crystal and Molecular Structure of (L-H)Au(PPh3).Et2O, where L = 1,3-dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one, NITRAZEPAM 106
Diimine Supported Group 10 Hydroxo, Oxo, Amido, and Imido Complexes 106
Synthesis, Solution Behavior, Molecular and Supremolecular Structures of the Water-soluble Gold(I) Saccharinate Complexes M[Au(Sac)2] (M = Na, K, NH4) 106
Synthesis of the first C-2 cyclopalladated derivatives of 1,3-bis(2-pyridyl)benzene. Crystal structures of [Hg(N-C-N)Cl], [Pd(N-C-N)Cl], and [Pd-2(N-C-N)(2)(mu-OAc)](2)[Hg2Cl6]. Catalytic activity in the heck reaction 105
Gold(III) derivatives with C(4)-aurated 1-phenylpyrazole RID D-3096-2011 105
Replacement of the chloride ligand in [Au(C,N,N)Cl][PF6] cyclometallated complexes by C, N, O and S donor anionic ligands RID D-3096-2011 104
Sintesi e studio della reattività di complessi di Au con proprietà citotossiche 103
Intramolecular C(sp2)-H Bond Activation in 6,6'-Dimethoxy-2,2'-Bipyridine with Gold(III). Crystal and Molecular Structure of the First N',C(3) “Rollover” Cycloaurated Derivative 103
Cyclometallated Derivatives of Palladium(II) with 1,4-Benzodiazepin-2-ones. Crystal Structure of (L-H)Pd(PPh3)Cl.CHCl3 (L = Prazepam: 7-chloro-1-cyclopropylmethyl-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one). Synthesis of Isoindolo-[2,1-d][1,4] benzodiazepine Derivatives by Reaction of [(L-H)PdCl]2 Species with Carbon Monoxide 103
Synthesis and Characterization of Palladium(II) and Platinum(II) Adducts and Cyclometalated Complexes of 6,6 '-Dimethoxy-2,2 '-bipyridine: C(sp(3))-H and C(sp(2))-H Bond Activations 103
Gold-based drug encapsulation within a ferritin nanocage: X-ray structure and biological evaluation as potential anticancer agent of the Auoxo3-loaded protein. 102
Totale 23.165
Categoria #
all - tutte 95.155
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.155


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202148 0 0 0 0 0 0 0 0 0 0 0 48
2021/2022939 163 9 3 7 6 10 52 71 93 48 87 390
2022/20232.028 215 116 27 385 222 349 10 238 313 13 86 54
2023/2024415 94 49 18 15 92 10 11 7 0 7 46 66
2024/20255.270 34 43 281 95 223 156 307 1.228 1.884 645 185 189
2025/202617.311 304 4.492 8.287 1.266 454 423 1.081 232 249 313 179 31
Totale 30.626